← Every applicant
Saptalis Pharms FDA Approvals
3 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| TOFACITINIB CITRATENew drugJun 9, 2026SOLUTION, ORAL |
| CYCLOSPORINENew drugJul 5, 2024EMULSION, OPHTHALMIC |
| LIKMEZNew drugSep 22, 2023SUSPENSION, ORAL |